| scholarly article | Q13442814 |
| P50 | author | Rudolf Jaenisch | Q90073 |
| Tomo Saric | Q47451205 | ||
| Kurt Pfannkuche | Q60674491 | ||
| Marius Wernig | Q74884461 | ||
| P2093 | author name string | Huamin Liang | |
| Juergen Hescheler | |||
| Alexey Kuzmenkin | |||
| Hongyan Luo | |||
| Guoxing Xu | |||
| Azra Fatima | |||
| Hardy Eichhorn | |||
| P2860 | cites work | Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 |
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution | Q29616187 | ||
| Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
| Generation of pluripotent stem cells from adult mouse liver and stomach cells | Q34750323 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4168-4180 | |
| P577 | publication date | 2009-08-24 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro | |
| P478 | volume | 23 |
| Q91796595 | 2-Cl-C.OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids |
| Q42550691 | Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes. |
| Q35958815 | Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells |
| Q27347592 | Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients |
| Q90402112 | Cardiac Stem Cells in the Postnatal Heart: Lessons from Development |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q37808482 | Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals |
| Q35031830 | Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction |
| Q38047654 | Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China |
| Q36460901 | Cardiotrophin-1 promotes cardiomyocyte differentiation from mouse induced pluripotent stem cells via JAK2/STAT3/Pim-1 signaling pathway |
| Q39314351 | Chondrogenic differentiation in vitro of murine two-factor induced pluripotent stem cells is comparable to murine embryonic stem cells |
| Q30597186 | Combining hypoxia and bioreactor hydrodynamics boosts induced pluripotent stem cell differentiation towards cardiomyocytes |
| Q34025541 | Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy |
| Q26863381 | Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering |
| Q34271595 | De novo myocardial regeneration: advances and pitfalls |
| Q59336250 | Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis |
| Q38752574 | Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. |
| Q51894379 | Differentiation of mouse embryonic stem cells into cardiomyocytes via the hanging-drop and mass culture methods. |
| Q39232292 | Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes. |
| Q55426574 | Direct Reprogramming of Adult Human Somatic Stem Cells Into Functional Neurons Using Sox2, Ascl1, and Neurog2. |
| Q42863198 | Distinct iPS Cells Show Different Cardiac Differentiation Efficiency |
| Q36016039 | Dynamic Support Culture of Murine Skeletal Muscle-Derived Stem Cells Improves Their Cardiogenic Potential In Vitro |
| Q42060920 | Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells |
| Q46080543 | Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts. |
| Q42405847 | Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells |
| Q43191299 | Forever young: induced pluripotent stem cells as models of inherited arrhythmias |
| Q38675863 | From iPSC towards cardiac tissue-a road under construction |
| Q28545881 | Gene Expression Profiling of H9c2 Myoblast Differentiation towards a Cardiac-Like Phenotype |
| Q48661614 | Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration. |
| Q58604035 | Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway |
| Q36788817 | Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells |
| Q36829190 | Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human Development |
| Q33693259 | Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar |
| Q37999164 | Guiding differentiation of stem cells in vivo by tetracycline-controlled expression of key transcription factors. |
| Q39788971 | High density cultures of embryoid bodies enhanced cardiac differentiation of murine embryonic stem cells |
| Q34430500 | Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability |
| Q34284385 | In vitro cardiomyogenic potential of human amniotic fluid stem cells |
| Q38014843 | Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine |
| Q36254286 | Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias |
| Q26823333 | Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease |
| Q27315974 | Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues |
| Q38603881 | Induced pluripotent stem cells in cardiovascular medicine |
| Q37801268 | Induced pluripotent stem cells: developmental biology to regenerative medicine |
| Q52607493 | Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy. |
| Q39566710 | Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line |
| Q34807143 | Methods to assess stem cell lineage, fate and function |
| Q36429641 | Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure |
| Q59072379 | Myocardial Reprogramming Medicine: The Development, Application, and Challenge of Induced Pluripotent Stem Cells |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q27334228 | N-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytes |
| Q92048774 | Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR |
| Q46170218 | Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis |
| Q34619318 | Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells |
| Q38063951 | Personalized cardiac regeneration by stem cells-Hype or hope? |
| Q45366611 | Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells |
| Q42248110 | Production of functional coagulation factor VIII from iPSCs using a lentiviral vector. |
| Q39176130 | Reprogramming approaches in cardiovascular regeneration |
| Q24567640 | Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. |
| Q39850212 | Stem cell therapy for ischemic heart disease |
| Q41137829 | Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation. |
| Q37642100 | Technical challenges in using human induced pluripotent stem cells to model disease |
| Q35563251 | Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling |
| Q30468033 | The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders |
| Q28513177 | The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation |
| Q51545602 | The future application of induced pluripotent stem cells in vascular regenerative medicine. |
| Q34186790 | Therapeutic opportunities: telomere maintenance in inducible pluripotent stem cells. |
| Q27015087 | Using human induced pluripotent stem cells to treat retinal disease |
Search more.